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In Brief
Pathogens require iron to proliferate in
vivo. Nairz and Ferring-Appel et al. show
that macrophage-specific ablation of iron
regulatory proteins 1 and 2, RNA-binding
factors that orchestrate mammalian iron
metabolism, impairs innate immunity
against Salmonella in mice, in part due to
failure of the host to limit microbial iron
acquisition.
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Macrophages are essential for systemic iron recy-
cling, and also control iron availability to pathogens.
Iron metabolism in mammalian cells is orchestrated
posttranscriptionally by iron-regulatory proteins
(IRP)-1 and -2. Here, we generated mice with selec-
tive and combined ablation of both IRPs in macro-
phages to investigate the role of IRPs in controlling
iron availability. These animals are hyperferritinemic
but otherwise display normal clinical iron parame-
ters. However, mutant mice rapidly succumb to
systemic infection with Salmonella Typhimurium, a
pathogenic bacterium that multiplies within macro-
phages, with increased bacterial burdens in liver
and spleen. Ex vivo infection experiments indicate
that IRP function restricts bacterial access to iron
via the EntC and Feo bacterial iron-acquisition sys-
tems. Further, IRPs contain Salmonella by promoting
the induction of lipocalin 2, a host antimicrobial fac-
tor that inhibits bacterial uptake of iron-laden sidero-
phores, and by suppressing the ferritin iron pool. This
work reveals the importance of the IRPs in innate
immunity.
INTRODUCTION
Iron supply for the hemoglobinization of new red blood cells in
the erythroid marrow depends largely on recycling of the metal
by the liver and spleen monocyte-macrophage system (MPS),
which clears old erythrocytes, frees iron from hemoglobin, and
exports the metal back into the circulation through the iron
exporter ferroportin (FPN, a.k.a. SLC40A1) (Ganz, 2013). Iron re-
cycling by the MPS diminishes in response to infection, which is
viewed as an innate defense mechanism to reduce the iron con-
centration in the circulation and thereby withhold the metal from254 Cell Host & Microbe 18, 254–261, August 12, 2015 ª2015 Elseviinvaders (Drakesmith and Prentice, 2012; Nairz et al., 2014).
Macrophage iron metabolism is thus critical both for securing
body iron sufficiency and immunity.
Systemic iron fluxes are controlled in part by the hormone hep-
cidin (a.k.a. HAMP), which inhibits iron export from macro-
phages by binding to and triggering the degradation of FPN
(Nemeth et al., 2004). In addition to humoral control of systemic
iron metabolism by hepcidin, iron metabolism is also regulated
cellularly by the iron regulatory proteins (IRP)-1 and -2 (a.k.a.
ACO1 and IREB2, respectively) (Ku¨hn, 2015). IRPs respond to
changes in cellular iron levels and in turn enact posttranscrip-
tional regulation of key iron metabolism genes via their interac-
tion with cis-regulatory iron responsive elements (IREs) present
on target mRNAs, including those encoding the transferrin re-
ceptor (TFR1), the ferritin-H (FTH1) and ferritin-L (FTL1) iron stor-
age proteins, and the iron exporter FPN. The role of macrophage
IRPs in body iron recycling and immunity is not known.
Here we use Cre/Lox technology to generate mice with cell-
type selective, complete loss of IRP expression in macrophages.
Earlier work investigating mice with complete IRP deficiency in
hepatocytes or duodenal enterocytes, respectively, had shown
early postnatal death in both cases, reflecting essential functions
of the IRPs for organismal survival (Galy et al., 2008, 2010). This
study reveals important molecular functions of the IRPs in the
control of macrophage iron metabolism and uncovers that at
least this mammalian cell type is viable without IRPs; it also un-
veils the critical importance of the IRP/IRE system for macro-
phage-mediated immunity and host resistance to infection with
intracellular bacteria.RESULTS
Role of IRPs in Macrophage and Body Iron Homeostasis
Animals homozygous for floxed Irp alleles (Aco1flox/flox,
Ireb2flox/flox) (Galy et al., 2005) were bred to a mouse line with
targeted insertion of Cre into the Lysozyme2 (Lyz2) locus
enabling selective expression of CRE recombinase in mono-
cytes/macrophages and neutrophils (Clausen et al., 1999).
Aco1flox/flox,Ireb2flox/flox,Lyz2+/Cre mice (designated IrpLyzCre(+))er Inc.
Figure 1. IRP Function in Macrophage Iron
Metabolism and Body Iron Recycling
(A) Left panels, western blot analysis (left panels) of
IRPs and IRP-target genes in BMDMs from mice
carrying either of the two or both floxed Irp1 (Aco1)
and Irp2 (Ireb2) alleles together or not with the
Lyz2-Cre gene, as indicated, and the corre-
sponding control cells. Histograms: qPCR anal-
ysis of IRP-target mRNA expression in doubly
deficient (Cre) versus control (noCre) BMDMs.
(B) Western blot (left) and qPCR (right) analysis of
IRP-target genes in doubly deficient (Cre) versus
control (noCre) peritoneal macrophages (PMF);
lysates from BMDMs (A) were used as a positive
control for FPN expression (bottom panels). The
qPCR data in (A) and (B) display transcript levels
as percentage of control (i.e. noCre cells) after
calibration to b-actin. FPN mRNA expression in
PMF is close to background and is indicated as
not detected (nd).
(C) Western blot (left) and qPCR (right) analysis of
IRP-target genes in Cre versus noCre BMDMs
exposed to the iron chelator DFO, the iron donor
hemin, or left untreated (ctr). For each gene,mRNA
levels are expressed as percentage of control (i.e.
untreated noCre BMDMs) after calibration to
b-actin. Statistical differences were assessed be-
tween treated and untreated cells for each geno-
type (asterisks) or between genotypes for each
treatment (upper case letter).
(D) Western blot analysis of FPN decay in BMDMs
exposed to increasing amounts of synthetic hep-
cidin; the asterisk indicates a crossreacting pro-
tein. For western blotting (A–D), b-actin (ACTB)
was used to ascertain equal loading. The vertical
dashed lines show where lanes were spliced
together in preparation of the image; all lanes were
from the same gel and from a single exposure.
(E) Consequences of IRP ablation in macrophages
on blood iron parameters in 2-, 4-, and 10-week-
old mice. TIBC, total iron binding capacity. Histo-
grams display averages ± SEM. The number of
mice (n) is indicated. P, Student’s t-test (*,ap <
0.05; **p < 0.01; ***p < 0.001). See also Figure S1
and Table S1.are born at Mendelian ratio and do not overtly differ from
Aco1flox/flox,Ireb2flox/flox,Lyz2+/+ control littermates (IrpLyzCre()).
To assess the consequences of IRP ablation for macrophage
iron metabolism, we analyzed bone marrow-derived macro-
phages (BMDMs) from IrpLyzCre(+) versus IrpLyzCre() animals; for
comparison, we also analyzed BMDMs deficient for either of
the two IRPs. Western blotting shows efficient ablation of IRP1
and/or IRP2 in BMDMs, with residual amounts of IRP (Figure 1A,
left) possibly reflecting mosaic activity of the Lyz2-Cre strain
(Tuckermann et al., 2007). IRP-target genes are not significantlyCell Host & Microbe 18, 254–261affected by single IRP1 deficiency, and
IRP2 disruption alone causes a minor in-
crease in FTL1 (Figure 1A, left). Contrast-
ing with this, the simultaneous ablation of
both IRPs causes a marked increase in
FPN, FTH1, and FTL1 expression (Fig-
ure 1A, left), most likely due to transla-tional derepression of the corresponding mRNAs (Galy et al.,
2013) and to a minor extent to increased mRNA expression (Fig-
ure 1A, right); double IRP deficiency expectedly decreases TFR1
protein and mRNA levels (Figure 1A). Similar to BMDMs, elicited
peritoneal macrophages (PMF) from IrpLyzCre(+) mice display high
ferritin and low TFR1 expression (Figure 1B); FPN protein and
mRNA could not be reliably detected in our PMF cultures (Fig-
ure 1B; see also Van Zandt et al., 2008). These results confirm
that IRP1 and IRP2 control key iron-handling molecules in mac-
rophages. They also show that each IRP can largely compensate, August 12, 2015 ª2015 Elsevier Inc. 255
for the lack of function in the other; hence the rest of our study
focuses on double IRP deficiency.
We next determined how IRP deficiency affects the response
of macrophages to iron challenge (Figure 1C). In IrpLyzCre()
BMDMs, iron chelation by deferoxamine (DFO) augments TFR1
mRNA and protein levels and slightly decreases FPN protein
expression; the expected suppression of ferritin could not be
observed because of already low basal expression. Opposite
to DFO, the iron source hemin suppresses TFR1 and stimulates
FTL1, FTH1, and FPN at the protein and less so at the mRNA
level. IRP-deficient BMDMs still respond to iron fluctuation with
further reduction of TFR1 upon iron loading (TFR1 mRNA ratio
hemin/non-treated: IrpLyzCre(), 0.18 ± 0.04; IrpLyzCre(+), 0.34 ±
0.08) and a slight increase upon iron chelation. These effects
could possibly reflect IRP-independent regulation of TFR1
mRNA turnover and/or changes in Tfr1 transcription. FTL1 pro-
tein expression remains unresponsive to DFO in IrpLyzCre(+) cells
and is slightly increased by hemin (Figure 1C, left) accompanied
by an increase of the FTL1 mRNA (Figure 1C, right; the same is
observed for FTH1); FPNmRNA stimulation by hemin (Figure 1C,
right) is accompanied by a marked FPN upregulation at the pro-
tein level (Figure 1C, left). These data indicate that ferritin regula-
tion in macrophages is dominated by IRP-dependent control of
ferritin translation, whereas FPN levels are set through both
IRP-dependent and IRP-independent regulatory pathways.
Importantly, IRP deficiency does not interfere with hepcidin-
mediated degradation of FPN (Figure 1D). However, because
basal FPN expression is elevated in IRP deficiency, higher doses
of hepcidin are required to suppress FPN. This shows that both
IRPs and hepcidin are important to set FPN levels and hence the
iron export capacity of macrophages.
Similar to primarymacrophage cultures (Figure 1), IRP ablation
increases ferritin expression posttranscriptionally in vivo, both in
liver and spleen macrophages (see Figure S1 available online);
FPN expression is augmented in liver (Figure S1A), but not in
spleen (Figure S1B). Of note, IrpLyzCre(+) mice display a marked
increase in plasma ferritin concentration (Figure 1E), as pre-
dicted for animals with augmented macrophage ferritin expres-
sion (Cohen et al., 2010). Although ferritin and FPN mediate,
respectively, macrophage iron retention and export, misregula-
tion of these critical iron management molecules in MPS cells
has no detectable impact on plasma iron levels and transferrin
saturation values (Figure 1E); hematological parameters and tis-
sue iron stores are also unaffected (Table S1). Hence, IRPs con-
trol key iron handling molecules in MPSmacrophages in vivo but
are dispensable for maintaining the body iron balance under
standard laboratory conditions.
The Macrophage IRP/IRE System Protects Mice against
Salmonella
Hypoferremia is a common response to infection (Nairz et al.,
2014). Part of this response involves Hepcidin stimulation and
subsequent inhibition of FPN-mediated iron efflux from macro-
phages. Although IRP deficiency antagonizes hepcidin-medi-
ated suppression of FPN (Figure 1D), it does not significantly
mitigate the hypoferremia induced by aseptic inflammatory stim-
uli inmice (Figure S2). This shows thatmacrophage iron retention
in response to acute inflammation relies predominantly on IRP-
independent mechanisms. It also suggests that macrophage256 Cell Host & Microbe 18, 254–261, August 12, 2015 ª2015 ElseviIRP deficiency would unlikely alter iron availability to microbes
present in the circulation. We thus investigated the impact on
iron availability toward intracellular pathogens, and infected
mice with Salmonella enterica serovar Typhimurium (designated
S.Tm). This Gram-negative bacterium persists within MPS cells,
including spleen and liver macrophages; it causes systemic dis-
ease in mice (Vazquez-Torres et al., 1999, 2004); and its depen-
dence on iron is well established (Nairz et al., 2007). Remarkably,
IrpLyzCre(+) mice succumb faster than IrpLyzCre() littermates when
exposed to a lethal dose of S.Tm (Figure 2A, top). This effect is
unrelated to the insertion of Cre into the Lyz2 locus, since
Lyz2+/Cre animals display the same survival as wild-type (Fig-
ure 2A, bottom). The higher vulnerability of IrpLyzCre(+) animals
to S.Tm is associated with higher bacterial multiplication in liver
and spleen (Figure 2B). Importantly, IrpLyzCre(+) mice are unable to
mount an adequate immune response against S.Tm, as evi-
denced by the blunted induction of several immune response
genes in liver and spleen (Figure 2C). These results reveal that
the macrophage IRP/IRE system is critically important for the
host defense against Salmonella (note that IRP depletion in
IrpLyzCre(+) neutrophils might also impact on mouse survival).
IRPs Limit Salmonella Proliferation by Controlling Iron
Bioavailability
To better define the mechanism(s) through which IRPs protect
mice against Salmonella, we infected primary macrophages
ex vivo. Consistent with the data obtained in vivo (Figure 2A),
PMF lacking IRP expression fail to restrict intracellular S.Tmpro-
liferation over time (Figure 3A); the same result was obtained
when infecting BMDMs (Figure 3B). Of note, IRP ablation does
not alter the capacity of macrophages to produce reactive oxy-
gen species upon infection with S.Tm (Figure S3A), nor the
engulfment of fluorescently labeled heat-killed S.Tm particles
(Figure S3B). Hence, a simple defect in the oxidative and phago-
cytic activities of IrpLyzCre(+) macrophages cannot account for
their reduced capacity to contain S.Tm. However, IRP deficiency
dampens the induction of several cytokines in macrophages in-
fected ex vivo (Figure 3C), mirroring the blunted immune
response observed in mice (Figure 2C); IrpLyzCre(+) cells appar-
ently also produce less nitric oxide than IrpLyzCre() (Figure 3D),
but this is not likely to explain their antimicrobial deficit toward
S.Tm (Figure S3C). IRP deficiency thus seems to broadly weaken
the macrophage innate immune response to S.Tm infection. To
determine whether the antimicrobial deficit of IrpLyzCre(+) macro-
phages is related to iron metabolism misregulation or reflects
potential iron-independent functions of the IRP/IRE system, we
added the iron chelator deferasirox (DFX) to macrophages dur-
ing infection. Importantly, iron chelation alone abrogates the
disadvantage conferred by IRP deficiency on macrophage anti-
bacterial activity (Figure 3E), showing that IRPs control intracel-
lular Salmonella proliferation at least in part through influencing
iron management.
IRPs Control Salmonella Iron Uptake through LCN2 and
Ferritin
To compare the effect of iron chelation on macrophage antimi-
crobial activity with the effects of genetic microbial iron limita-
tion, we infected macrophages with a triple sit feo entC mutant
strain of S.Tm defective for the three main iron acquisitioner Inc.
Figure 2. Macrophage IRPs Protect Mice
against Infection with Salmonella Typhi-
murium
(A) Top, IrpLyzCre(+) mice (Cre) and control litter-
mates (noCre) were subjected to systemic infec-
tion with 500 CFU of Salmonella Typhimurium
(S.Tm). The representative Kaplan-Meyer curve
displays mouse survival over time. Bottom, same
experiment with Lyz2+/Cre versus wild-type mice.
(B) IrpLyzCre(+) and IrpLyzCre() mice were injected
with a low dose (200 CFU) of S.Tm and the bac-
terial load of liver (top) and spleen (bottom) tissues
was determined at different time points after
infection. The data expressed as CFU per gram of
tissue were log transformed.
(C) The induction of immune response genes in
liver and spleen was assayed by qPCR 6 hr after
infection, i.e., before differences in bacterial loads
(B) are manifest. The data are expressed as per-
centage of control (i.e., noCre animals injected
with vehicle) after calibration to tubulin (TUBB5)
mRNA. (B and C) The data are displayed as box
and whiskers with 10 to 90 percentiles (outliers are
represented as dots). (n) indicates the number of
mice. p, (A), long-rank test; (B) and (C), Student’s
t test (*p < 0.05; **p < 0.01; ***p < 0.001; ns, not
significant). See also Figure S2.pathways (Crouch et al., 2008). Proliferation of this mutant is
expectedly reduced compared to wild-type bacteria (Figure 4A).
Importantly, the sit feo entC S.Tm mutant proliferates almost
identically in IrpLyzCre(+) as in IrpLyzCre() (Figure 4A). Likewise,
while microbial 59Fe uptake is 3-fold higher when bacteria
infect IRP-deficient versus control macrophages (Figure 4B),
iron acquisition by the sit feo entC S.Tm mutant is diminished
and unaffected by the IRP status of the host cell (Figure 4B).
These results demonstrate that the macrophage IRP/IRE system
limits bacterial iron assimilation and growth.
S.Tm acquires elemental ferrous iron via the SitABCD and Feo
systems and takes up ferric iron with the help of siderophores
(Osman and Cavet, 2011). To determine which iron uptakeCell Host & Microbe 18, 254–261pathway is targeted by the IRPs, we in-
fected macrophages with bacteria defi-
cient for either of the three iron uptake
systems. While the antimicrobial deficit
of IrpLyzCre(+) macrophages is evident
withS.Tm lacking sitABCD, it is abolished
when the bacteria lack the siderophore
iron uptake pathway (entC) (Figure 4C);
disruption of the Feo system has an inter-
mediate effect. IRPs thus restrain sidero-
phore-mediated bacterial iron uptake and
limit elemental iron acquisition via the Feo
but not the SitABCD system. In line with
those results, we find that mice with
macrophage IRP deficiency display the
same survival as wild-type littermates
when infected with entC or feo mutant
bacteria, respectively, but remain signifi-
cantly more vulnerable to infection withthe sitABCD mutant strain (Figure S4). Altogether these data
show that macrophage IRPs limit Salmonella siderophore- and
Feo-mediated iron assimilation.
Finally, we sought to determine how loss of IRP function pro-
motes bacterial iron assimilation. Lipocalin 2 (LCN2) is a host
antimicrobial factor induced upon infection that inhibits bacterial
uptake of iron-laden siderophores (Flo et al., 2004; Raffatellu
et al., 2009; Deriu et al., 2013). As Lcn2 induction is impaired in
IrpLyzCre(+) macrophages (Figure 3C), we hypothesized that these
cells fail to limit bacterial iron acquisition due to insufficient LCN2
production. To test this, we either added recombinant LCN2 to
the culture medium of infected macrophages, or inhibited
endogenous LCN2with an anti-LCN2 antibody. The antibacterial, August 12, 2015 ª2015 Elsevier Inc. 257
Figure 3. IRPs Promote Macrophage Immunity and Inhibit Salmo-
nella Proliferation
(A) PMF from IrpLyzCre(+) (Cre) versus IrpLyzCre() (noCre) mice were infected
ex vivo with S.Tm, and intracellular bacterial proliferation (averages ± SEM)
was recorded over time. IRP-deficient PMF exhibit a tendency for reduced
anti-bacterial activity 12 hr after infection reaching statistical significance at
the 24 hr time point.
(B) IrpLyzCre(+) BMDMs display the same inability to contain S.Tm proliferation
24 hr postinfection.
(C) The concentration of cytokines in the culture medium of PMF was deter-
mined 24 hr after infection with S.Tm. The data are displayed as box and
whiskers with 10–90 percentiles.
(D and E) PMF were infected as in (A) in the presence of the iron chelator
Deferasirox (DFX) versus vehicle (ctr.), and the intracellular bacterial load
(averages ± SEM) was determined 24 hr later. The sample size (n) is indicated.
P, Student’s t test (*p < 0.05; **p < 0.01; ***p < 0.001). See also Figure S3.deficit of IrpLyzCre(+) macrophages is fully reverted by exogenous
addition of LCN2 (Figure 4D, left) and is only slightly affected by
inhibition of endogenous LCN2 (Figure 4D, right); LCN2 inhibition
in IrpLyzCre() macrophages at least partially phenocopies the
antibacterial deficit of IRP null cells (Figure 4D, right). In contrast258 Cell Host & Microbe 18, 254–261, August 12, 2015 ª2015 Elsevito LCN2, exogenous addition of TNFA and/or IL6, whose induc-
tion is also impaired in IrpLyzCre(+) macrophages (Figure 3D), en-
hances the bactericidal activity of both IrpLyzCre(+) and IrpLyzCre()
cells but does not rescue IRP deficiency (Figure S4B). These re-
sults show that the inability of IRP-deficient macrophages to
combat S.Tm is at least partly due to LCN2 misregulation.
IrpLyzCre(+) BMDMs also display a tendency toward increased
total nonheme iron levels (ferrozine assay: 12.9 ± 1.9 versus
7.5 ± 1.5 mmol Fe/g total protein in IrpLyzCre(+) versus control
BMDMs, n = 5 in each group, p = 0.07 Student’s t test). Iron
loading in IrpLyzCre(+) cells occurs in spite of reduction of the
TFR1 iron uptake molecule and stimulation of the FPN iron
exporter (Figure 1), and could possibly reflect sequestration of
themetal into the overabundant ferritin (Galy et al., 2013). We hy-
pothesized that iron bound to ferritin in IrpLyzCre(+) macrophages
(Figures 1A and 1B) constitutes a pool of metal exploitable by
S.Tm. To test this, IrpLyzCre() and IrpLyzCre(+) macrophages
were loaded with 59Fe-citrate prior infection, and samples were
collected at different time points to determine, respectively, the
uptake of 59Fe by S.Tm and the amount of 59Fe in ferritin immu-
noprecipitates (IPs) (Figure 4E). At time zero of infection, ferritin
from IrpLyzCre(+) macrophages contains about 2.3-fold more
59Fe compared to IrpLyzCre() (Figure 4E, upper histogram). This
result confirms that cellular iron accumulates within the excess
of ferritin in IRP-deficient cells. Over the course of infection,
the amount of 59Fe associated with ferritin decreases both in
IrpLyzCre() and IrpLyzCre(+) macrophages (Figure 4E), indicating
that the pool of iron bound to ferritin is indeed mobilized while
S.Tm multiplies. Importantly, the initially enlarged ferritin-bound
iron pool of IrpLyzCre(+) macrophages is consumed and becomes
nearly identical to IrpLyzCre() 12 hr after infection. This experi-
ment shows that the excess of ferritin in IrpLyzCre(+) macrophages
provides a surplus of iron contributing to increased bacterial iron
uptake.
In conclusion, macrophage IRPs are critical for host resistance
to infection with S.Tm in mice. Although additional mechanisms
may contribute, the restriction of S.Tm iron acquisition and pro-
liferation by promotion of LCN2 synthesis and suppression of the
ferritin iron pool emerge as underlying mechanisms.
DISCUSSION
Iron recycling and storage by macrophages are critical for sys-
temic iron homeostasis and host defense (Nairz et al., 2014).
While the role of hepcidin in the control of macrophage iron
fluxes and inflammatory hypoferremia is recognized (Ganz,
2013), additional hepcidin-independent modes of iron meta-
bolism regulation are being discovered (Deschemin and Vaulont,
2013; Guida et al., 2015). Although it represents a key regulator
of cellular iron transport and storage, the role of the IRP/IRE sys-
tem in macrophage iron metabolism has not yet been under-
stood. Through genetic disruption of the macrophage IRP/IRE
system in mice, this work uncovers the important function of
the macrophage IRPs, including the importance of the IRP/IRE
system for innate immunity.
Disruption of IRP function in macrophages affects their iron
storage and export capacity, similar to enterocytes and hepato-
cytes (Galy et al., 2008, 2010). Surprisingly, IrpLyzCre(+) mice
develop normally, are viable and fertile, and show no sign ofer Inc.
Figure 4. IRPs Control Bacterial Iron Uptake through LCN2 and
Ferritin
(A) PMF from IrpLyzCre(+) (Cre) versus IrpLyzCre() (noCre) animals were infected,
respectively, with a wild-type (S.TmWT) or a triple mutant strain (S.Tm triple) of
S.Tm deficient for the three main bacterial iron uptake pathways; intracellular
bacterial proliferation was assayed 24 hr later.
(B) PMF were infected as in (A) in the presence of a 59Fe tracer and microbial
59Fe uptake was determined 24 hr postinfection.
(C) PMFwere infected with S.Tmmutant strains deficient for either of the three
main iron uptake pathways, as indicated below the histogram; bacterial pro-
liferation was measured 24 hr later. Numbers above the bars indicate the
Cre/noCre ratios.
(D) Cre versus noCre BMDMs were infected, respectively, in the presence of
recombinant LCN2 versus vehicle (left) or an anti-LCN2 antibody versus iso-
type control (right).
(E) BMDMswere labeled with a 59Fe tracer prior to infection, and samples were
collected at different time points to determine, respectively, bacterial number,
bacterial iron uptake, and the amount of 59Fe in ferritin immunoprecipitates.
Bacterial 59Fe uptake (black lines, left axis) is indicated as percentage of noCre
BMDMs 12 hr after infection; ferritin-associated 59Fe (red lines, right axis) is
given as percentage of noCre BMDMs at time 0 hr. Note that the inverse
correlation between ferritin-bound iron levels and bacterial iron uptake is
qualitative and does not necessarily imply the uptake of all the iron associated
with ferritin by S.Tm. Data are presented as averages ± SEM. The sample size
(n) is indicated. P, Student’s t test (*p < 0.05; **p < 0.01; ***p < 0.001). See also
Figure S4.
Cell Hosillness when maintained in a standard laboratory environment.
This contrasts with the severe wasting and perinatal lethality of
mice with constitutive, cell-specific loss of IRP function in enter-
ocytes or hepatocytes, respectively (Galy et al., 2008, 2010).
Furthermore, macrophage IRP function seems dispensable for
maintaining systemic iron homeostasis under steady-state con-
ditions. Changes in macrophage iron recycling and storage in
IrpLyzCre(+) mice are apparently compensated for by the organ-
ism. Mosaic activity of the Lyz2-Cre deletor strain (Tuckermann
et al., 2007) might also mitigate the iron phenotype of IrpLyzCre(+)
mice. Importantly, IRPs in macrophages strongly influence
plasma ferritin concentration, a widely used clinical parameter.
This result supports earlier work concluding that macrophages
represent a major source of ferritin in the blood (Cohen et al.,
2010).
Iron holds a key position at the host-pathogen interface (Nairz
et al., 2014). Herewe demonstrate thatmacrophage IRP function
is protective against Salmonella. IRP ablation in macrophages
broadly hampers the immune response to S.Tm infection. IRPs
most likely regulate the immune response in an indirect manner,
since the transcripts encoding the cytokines assayed in our
study are devoid of IRE, as assessed using the sIRES tool (Cam-
pillos et al., 2010). The HIF2a (hypoxia-inducible factor 2 alpha,
a.k.a. EPAS1) transcription factor could be a possible intermedi-
ate linking IRP function to cytokine regulation. Indeed, the HIF2a
mRNA bears an IRE in its 50 UTR (Sanchez et al., 2007), and
HIF2a is required for cytokine induction in macrophages (Imtiyaz
et al., 2010). However, IRP ablation leads to HIF2a overexpres-
sion (Galy et al., 2013) and would thus be predicted to potentiate
the immune response, which is opposite to what we observe.
IRPs could influence cytokine production via modulation of
cellular iron levels. Iron indeed modulates the immune response
in multiple ways. On the one hand, the metal can negatively
affect immune defense pathways (Nairz et al., 2014), but it also
seems to promote toll-like receptor signaling (Wang et al.,t & Microbe 18, 254–261, August 12, 2015 ª2015 Elsevier Inc. 259
2009), and elevation of intracellular iron levels in FPN-deficient
BMDMs increases cytokine expression upon LPS stimulation
(Zhang et al., 2011). Although IRP deficiency has pleiotropic
effects on the immune response and impaired cytokine produc-
tion could play an important role, the failure of IRP-deficient
macrophages to combat S.Tm can be imputed at least in part
to their inability to limit microbial iron acquisition. We identify
two molecular mechanisms by which IRPs restrict bacterial
iron uptake. First, IRPs are needed for sufficient host LCN2 pro-
duction and restriction of siderophore-mediated iron uptake;
since, similar to cytokines, the LCN2 mRNA does not bear a
recognizable IRE, the exact mechanisms of IRP-dependent
LCN2 regulation remain to be defined. It will also be interesting
to determine how S.Tm mobilizes the iron bound to ferritin. In-
duction of ferritin degradation, as observed inNeisseria meningi-
tidis-infected cells, is one possible scenario (Larson et al., 2004).
Of note, reduction of macrophage iron levels through enhance-
ment of FPN-mediated iron efflux is viewed as a defense mech-
anism against intracellular bacteria, including S.Tm (Chlosta
et al., 2006; Paradkar et al., 2008; Nairz et al., 2007). S.Tm pro-
liferation in IRP-deficient BMDMs is increased in spite of FPN
overexpression. This indicates that high FPN expression alone
cannot inhibit intracellular bacterial proliferation when ferritin is
hyperinduced.
EXPERIMENTAL PROCEDURES
Mice
All mouse lines were backcrossed to C57BL/6 animals for at least ten gener-
ations. For all studies of IrpLyzCre(+) mice, control animals consisted of
IrpLyzCre() littermates. Unless specified, 10- to 12-week-old male mice were
used. For infection experiments, mice were injected (i.p.) with the indicated
CFU of S.Tm diluted in PBS (control mice received PBS alone). To increase
macrophage number in peritoneal exudates, mice received (i.p.) 0.075 ml of
4% water-solubilized thiogylcolate medium (Sigma-Aldrich, Taufkirchen, Ger-
many) per g body weight. Mice were kept under a constant light/dark cycle on
a standard diet and had access to food and water ad libitum. They were eu-
thanised by CO2 inhalation to collect tissues, macrophages, or blood. Animal
handling was in accordance with approved guidelines from the EMBL, the
Medical University of Innsbruck Animal ethics committee, and the Austrian
Ministry for Science and Education (approvals: BMWF-66.011/0151-II/3b/
2011 and BMWFW-66.011/0111-WF/V/3b/2014).
Macrophages
BMDMs and PMF were isolated and grown as described previously (Ferring-
Appel et al., 2009). For iron challenges, BMDMs were treated for 12 hr with
100 mM heme arginate (Leiras Oy, Turku, Finland) or 100 mM DFO (Sigma-
Aldrich), respectively; for hepcidin treatment, cells were exposed for 5 hr to
increasing doses of hepcidn 25 (Peptides International, Louisville, KY). For
all treatments, cells received vehicle as control. For infection experiments,
macrophages were infected at a MOI of 10, and intracellular bacterial multipli-
cation was determined as described previously (Nairz et al., 2013). To test the
role of LCN2, macrophages were infected in the presence of recombinant
murine LCN2 (100 ng/ml, R&D Systems GmbH,Wiesbaden-Nordenstadt, Ger-
many) versus vehicle, or with a rat monoclonal anti-mouse LCN2 antibody
(25 mg/ml, clone 228418, R&D Systems GmbH) versus isotype control
(25 mg/ml, clone 5447, R&D Systems GmbH). To test the influence of iron che-
lation, infected macrophages were treated with 100 mM DFX (Novartis, Basel,
Switzerland) versus vehicle.
Bacterial Strains
We used the S. Tm. wild-type strain ATCC 14028s and isogenic mutant deriv-
atives deficient for either entC::aph, Dsit::bla, and Dfeo::Tn10 (Tetr), respec-
tively, or all three iron acquisition pathways (Crouch et al., 2008).260 Cell Host & Microbe 18, 254–261, August 12, 2015 ª2015 ElseviStatistical Analyses
Data are presented as mean ± SEM unless otherwise specified. Statistical
analyses were performed using the Prism software (GraphPad Software, La
Jolla, CA). Differences between twomean values were evaluated by two-tailed
Student’s t test (data were log transformed for the comparison of bacterial
loads and mRNA levels of immune response genes). Multiple groups were
compared by one-way ANOVA with Bonferroni’s post hoc analysis. To
compare survival curves the log-rank test was used. A p value < 0.05 was
considered significant.
Additional and detailed experimental procedures can be found in the Sup-
plemental Information.
SUPPLEMENTAL INFORMATION
Supplemental Information includes four figures, one table, and Supplemental
Experimental Procedures and can be found with this article at http://dx.doi.
org/10.1016/j.chom.2015.06.017.
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